A. Rhodes

Epidemiology · 2005–2021

A researcher in the Science corpus: 17 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

• Epidemiology — 321 citations into it
• Endocrinology, Diabetes and Metabolism — 66 citations into it

Whom A. Rhodes trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. G. Guyatt
2. Mitchell M. Levy
3. Djillali Annane
4. N. Steigbigel
5. P. Marik
6. R. Bellomo
7. J. Kress

Who trusts A. Rhodes overall

1. Mitchell M. Levy
2. H. Prescott
3. Laura Evans
4. M. Cecconi
5. Min Huang

Papers from A. Rhodes's perspective

Ordered by how strongly the researchers A. Rhodes trusts endorse each paper. Same corpus, a different order for every researcher.

1. Hydrocortisone therapy for patients with septic shock. (New England Journal of Medicine)
2. APACHE II: A severity of disease classification system
3. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care (Critical Care Medicine)
4. Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. (American Journal of Respiratory and Critical Care Medicine)
5. GRADE guidelines: 2. Framing the question and deciding on important outcomes. (Journal of Clinical Epidemiology)
6. Intensive insulin therapy in the medical ICU. (New England Journal of Medicine)
7. Drotrecogin alfa (activated) in adults with septic shock. (New England Journal of Medicine)
8. Prone positioning in severe acute respiratory distress syndrome. (New England Journal of Medicine)
9. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock (Current Infectious Disease Reports)
10. Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. (New England Journal of Medicine)

Their papers

• Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) — 1,144 citations
• Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19) (2020) — 2,417 citations
• Sepsis and septic shock. (2018) — 1,076 citations
• The Surviving Sepsis Campaign Bundle: 2018 update (2018) — 1,317 citations
• Adjunctive Glucocorticoid Therapy in Patients with Septic Shock (2018) — 819 citations
• Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 (2017) — 7,369 citations
• Standards for definitions and use of outcome measures for clinical effectiveness research in perioperative medicine: European Perioperative Clinical Outcome (EPCO) definitions A statement from the ESA-ESICM joint taskforce on perioperative outcome measures (2015) — 765 citations
• Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine (2014) — 1,527 citations
• DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients? (2014) — 1,011 citations
• Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012 (2013) — 6,614 citations
• The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material (2012) — 1,348 citations
• Drotrecogin alfa (activated) in adults with septic shock. (2012) — 1,264 citations
• A Systematic Review and Meta-Analysis on the Use of Preemptive Hemodynamic Intervention to Improve Postoperative Outcomes in Moderate and High-Risk Surgical Patients (2011) — 813 citations
• Assessing and grading congestion in acute heart failure: a scientific statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine (2010) — 714 citations
• Identification and characterisation of the high-risk surgical population in the United Kingdom (2006) — 668 citations
• Early goal-directed therapy after major surgery reduces complications and duration of hospital stay. A randomised, controlled trial [ISRCTN38797445] (2005) — 639 citations
• [Executive summary of the guidelines on the diagnosis and treatment of acute heart failure]. (2005) — 1,080 citations